首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >DRG-Based Hospital Payment Systems and Technological Innovation in 12 European Countries
【24h】

DRG-Based Hospital Payment Systems and Technological Innovation in 12 European Countries

机译:支付系统和DRG-Based医院技术创新在12个欧洲国家

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objectives: To assess how diagnosis-related group-based (DRG-based) hospital payment systems in 12 European countries participating in the EuroDRG project pay and incorporate technological innovation. Methods: A standardized questionnaire was used to guide comprehensive DRG system descriptions. Researchers from each country reviewed relevant materials to complete the questionnaire and drafted standardized country reports. Two characteristics of DRG-based hospital payment systems were identified as particularly important: the existence of short-term payment instruments encouraging technological innovation in different countries, and the characteristics of long-term updating mechanisms that assure technological innovation is ultimately incorporated into DRG-based hospital payment systems. Results: Short-term payment instruments and long-term updating mechanisms differ greatly among the 12 European countries included in this study. Some countries operate generous short-term payment instruments that provide additional payments to hospitals for makinguse of technological innovation (e.g., France). Other countries update their DRG-based hospital payment systems very frequently and use more recent data for updates. Conclusions: Generous short-term payment instruments to promote technological innovation should be applied carefully as they may imply rapidly increasing health-care expenditures. In general, they should be granted only if rigorous analyses have demonstrated their benefits. If the evidence remains uncertain, coverage with evidence development frameworks or frequent updates of the DRG-based hospital systems may provide policy alternatives. Once the data and evidence base is substantially improved, future research should empirically investigate how different policy arrangements affect the adoption and use of technological innovation and health-care expenditures.
机译:目的:评估diagnosis-related组的(DRG-based)医院支付系统欧洲12个国家参与EuroDRG项目支付并整合技术创新。是用于指导综合诊断相关系统描述。回顾了相关资料完成问卷调查和起草国家标准报告。确定为医院支付系统特别重要:的存在短期支付工具鼓励不同国家的技术创新,和长期更新的特点机制,保证技术创新最终纳入DRG-based吗医院的支付系统。支付工具和长期更新机制有很大的不同在12个欧洲人国家纳入本研究。慷慨的短期支付工具进行操作提供额外支付给医院makinguse技术创新(例如,法国)。医院经常支付系统和使用最近更新的数据。慷慨的短期支付工具促进技术创新小心,因为他们可能意味着快速应用增加医疗支出。他们应该被授予只有严格的分析展示了他们的福利。仍不确定,保险的证据开发框架或频繁的更新DRG-based医院系统可能提供政策替代方案。大幅改善,未来的研究应该实证研究不同的政策安排影响的采用和使用技术创新和医疗支出。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号